Glasgow is set to gain a substantial life sciences boost after a digital chemistry company announced plans to establish its global headquarters and research and development centre at the University of Glasgow’s Health Innovation Hub in Govan.
Public backing and private investment combine
The expansion project is worth £89.9 million in total, with the public sector contributing £22 million and the company itself putting in £67.9 million. The public pledge comprises £16 million from Scottish Enterprise and £6 million from the UK government.
Officials expect the programme to support as many as 300 new jobs as the firm scales up operations in Scotland and grows its automated chemical-manufacturing capability.
What the company does and why it matters
Founded in 2019 as a university spinout, the firm combines robotics and artificial intelligence to automate the design, manufacture and testing of chemical compounds. That automated pipeline is aimed at speeding discovery in medicines and advanced materials, reducing time and cost for research teams.
The prospect of faster, more cost-efficient discovery has clear appeal to pharmaceutical developers and manufacturers of novel materials. By embedding an integrated automated chain in Glasgow, the company will anchor a high-tech capability that can support both academic collaboration and commercial scale-up.
Officials frame the investment as a vote of confidence
“Chemify’s investment is a powerful vote of confidence in Scotland as a place to scale innovative deep-tech businesses,”
The comment came from Scottish Enterprise’s chief executive, who said the funding would accelerate the company’s growth and create opportunities across chemistry, advanced manufacturing and life sciences. He noted the firm had received support from the agency since 2023 and described the expansion as evidence of the strength of Scotland’s innovation environment.
- Location: University of Glasgow Health Innovation Hub, Govan (Glasgow Riverside Innovation District)
- Founding year: 2019 (University of Glasgow spinout)
- Technology: Robotics + AI to automate chemical compound design, manufacture and testing
- Potential jobs: Up to 300
Funding breakdown
| Contributor | Amount |
|---|---|
| Chemify (company) | £67.9m |
| Scottish Enterprise | £16m |
| UK government | £6m |
| Total | £89.9m |
Putting public and private funds together will help the firm scale its automated manufacturing operations in Glasgow while situating strategic headquarters and R&D functions in the city.
Context and uncertainties
The announcement aligns with wider UK and Scottish strategies to cultivate deep-tech clusters and life sciences jobs. Public investment can be decisive in de-risking expansion for capital-intensive ventures that blend hardware, software and chemistry.
However, the precise job numbers remain estimates and will depend on the company’s growth trajectory, commercial contracts and successful scaling of its automated processes. The timeline for full occupation of the Govan hub and the schedule for expanding manufacturing were not specified in the announcement.
For researchers and firms in the life sciences, the addition of a domestic, automated discovery capability could shorten development cycles and lower cost barriers for early-stage work. For the city, the move may strengthen the innovation district’s cluster of health and technology assets and attract further private investment.
As the project proceeds, key indicators to watch will include the number of skilled roles created locally, the degree of collaboration with university researchers, and how rapidly the company translates its automated chemistry tools into commercial partnerships or licensed technologies.
The deal represents an explicit example of public and private capital combining to back a deep-tech scale-up rooted in both robotics and machine learning — a sector where the engineering of hardware and the training of models must advance in step for commercial success.
